Literature DB >> 23780553

Outcomes and predictors of reintervention in patients with pulmonary atresia and intact ventricular septum treated with radiofrequency perforation and balloon pulmonary valvuloplasty.

Matthew C Schwartz1, Andrew C Glatz, Yoav Dori, Jonathan J Rome, Matthew J Gillespie.   

Abstract

Radiofrequency perforation and valvuloplasty (RFV) is an effective initial treatment in patients with pulmonary atresia and intact ventricular septum (PA-IVS) and mild to moderate right ventricle and tricuspid valve hypoplasia. Outcomes and risk factors for the need for additional interventions in these patients are poorly defined. All patients with PA-IVS who underwent RFV at our center between January 2000 and July 2011 were reviewed. Twenty-three patients met the inclusion criteria. All patients underwent successful valvuloplasty with no procedural deaths and one major complication. Excluding two patients with limited follow-up, 6 (29 %) patients underwent no subsequent interventions, whereas 9 (42 %) patients underwent surgical right-ventricular outflow tract augmentation. All except one patient with adequate follow-up have a biventricular circulation with saturation >92 %. Patients who did not undergo any right-ventricular outflow tract intervention after valvuloplasty had a significantly lower gradient across the pulmonary valve after valvuloplasty (9.9 mmHg ± 8.4 vs. 19.1 mmHg ± 10.4, p = 0.05). Significantly more patients who received a supplemental source of pulmonary blood flow had a tricuspid valve z-score <-0.7 compared with patients who did not receive supplemental blood flow [2 (15 %) vs. 7 (70 %), p = 0.008]. In our cohort of patients with PA-IVS, radiofrequency perforation with valvuloplasty was an effective and safe first step in establishing a biventricular circulation. Postvalvuloplasty pulmonary valve gradient may be predictive of subsequent outflow tract intervention, and tricuspid hypoplasia may be predictive of the need for a supplemental source of pulmonary blood flow.

Entities:  

Mesh:

Year:  2013        PMID: 23780553     DOI: 10.1007/s00246-013-0733-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  10 in total

1.  Long-term outcome following catheter valvotomy for pulmonary atresia with intact ventricular septum.

Authors:  Henry Chubb; Erkki Pesonen; Sivasankaran Sivasubramanian; Shane M Tibby; John M Simpson; Eric Rosenthal; Shakeel A Qureshi
Journal:  J Am Coll Cardiol       Date:  2012-04-17       Impact factor: 24.094

2.  Predictors of reintervention in neonates with critical pulmonary stenosis or pulmonary atresia with intact ventricular septum.

Authors:  Ghassan Shaath; Mansour Al Mutairi; Omar Tamimi; Ali Alakhfash; Mostafa Abolfotouh; Fahad Alhabshan
Journal:  Catheter Cardiovasc Interv       Date:  2012-01-10       Impact factor: 2.692

Review 3.  Management algorithm in pulmonary atresia with intact ventricular septum.

Authors:  Mazeni Alwi
Journal:  Catheter Cardiovasc Interv       Date:  2006-05       Impact factor: 2.692

4.  Concomitant stenting of the patent ductus arteriosus and radiofrequency valvotomy in pulmonary atresia with intact ventricular septum and intermediate right ventricle: early in-hospital and medium-term outcomes.

Authors:  Mazeni Alwi; Kok-Kuan Choo; Nomee A M Radzi; Hasri Samion; Kiew-Kong Pau; Chee-Chin Hew
Journal:  J Thorac Cardiovasc Surg       Date:  2011-01-11       Impact factor: 5.209

5.  Pulmonary atresia with intact ventricular septum percutaneous radiofrequency-assisted valvotomy and balloon dilation versus surgical valvotomy and Blalock Taussig shunt.

Authors:  M Alwi; K Geetha; A A Bilkis; M K Lim; S Hasri; A L Haifa; A Sallehudin; R Zambahari
Journal:  J Am Coll Cardiol       Date:  2000-02       Impact factor: 24.094

6.  Pulmonary atresia with intact ventricular septum: range of morphology in a population-based study.

Authors:  Piers E F Daubeney; David J Delany; Robert H Anderson; George G S Sandor; Zdenek Slavik; Barry R Keeton; Steven A Webber
Journal:  J Am Coll Cardiol       Date:  2002-05-15       Impact factor: 24.094

7.  Outcomes of transcatheter approach for initial treatment of pulmonary atresia with intact ventricular septum.

Authors:  Babar Sultan Hasan; Victor Bautista-Hernandez; Doff B McElhinney; Joshua Salvin; Peter C Laussen; Ashwin Prakash; Robert L Geggel; Frank A Pigula
Journal:  Catheter Cardiovasc Interv       Date:  2012-10-17       Impact factor: 2.692

8.  Percutaneous balloon valvotomy in pulmonary atresia with intact ventricular septum: impact on patient care.

Authors:  Tilman Humpl; Björn Söderberg; Brian W McCrindle; David G Nykanen; Robert M Freedom; William G Williams; Lee N Benson
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690

9.  Long-term results of catheter-based treatment of pulmonary atresia and intact ventricular septum.

Authors:  M Marasini; P F Gorrieri; G Tuo; L Zannini; P Guido; M Pellegrini; S Bondanza; M G Calevo; G Pongiglione
Journal:  Heart       Date:  2009-05-28       Impact factor: 5.994

10.  Pulmonary atresia with intact ventricular septum: limitations of catheter-based intervention.

Authors:  Yasutaka Hirata; Jonathan M Chen; Jan M Quaegebeur; William E Hellenbrand; Ralph S Mosca
Journal:  Ann Thorac Surg       Date:  2007-08       Impact factor: 4.330

  10 in total
  3 in total

1.  Long-Term Outcomes After an Individualized Strategy in Patients with Pulmonary Atresia and Intact Ventricular Septum.

Authors:  Jun Muneuchi; Mamie Watanabe; Yuichiro Sugitani; Hirohito Doi; Takashi Furuta; Masaru Kobayashi; Hiroki Ezaki; Yoshie Ochiai
Journal:  Pediatr Cardiol       Date:  2021-09-24       Impact factor: 1.655

2.  Outcome Predictors in Catheter Interventions for Severe Right Ventricular Outflow Tract Obstructions.

Authors:  Sonia A El-Saiedi; Wael A Attia; Ashraf Abd El-Rahim; Baher M Hanna
Journal:  J Saudi Heart Assoc       Date:  2022-04-11

3.  Novel echocardiographic score to predict duct-dependency after percutaneous relief of critical pulmonary valve stenosis/atresia.

Authors:  Mario Giordano; Giuseppe Santoro; Gianpiero Gaio; Maurizio Cappelli Bigazzi; Raffaella Esposito; Raffaella Marzullo; Antonio Di Masi; Maria Teresa Palladino; Maria Giovanna Russo
Journal:  Echocardiography       Date:  2022-04-24       Impact factor: 1.874

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.